Reducing Activities: company scaling back some business operations while continuing others
Stay Scaling Back
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world’s top 15 biopharmaceutical companies in terms of oncology sales.
Reducing Activities: company scaling back some business operations while continuing others
Stay Scaling BackContinues serving patients. March 29, 2022 "In line with our relentless commitment to serving patients, we will continue to tackle their healthcare needs regardless of their race, sex, nationality, ethnicity, country of origin, language, or religion. We support global sanctions, and we will take all precautionary measures to comply with them. We have suspended several promotional activities in Russia, including advertising and participation to non-scientific congresses. Additionally, we will not initiate any new clinical trials." Revenue decreased in 2024 vs 2023 by more than -10%.